Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal Transplantation

This study has been completed.
Hoffmann-La Roche
Information provided by:
University of Miami Identifier:
First received: May 19, 2008
Last updated: May 23, 2008
Last verified: May 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: October 2006 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):